{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:55:14Z","timestamp":1792684514511,"version":"4.5.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/mark\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Emerging Microbes &amp; Infections"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/22221751.2025.2601372","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T10:16:41Z","timestamp":1765793801000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses from humans in the United States, October 2024 to February 2025"],"prefix":"10.1080","volume":"15","author":[{"given":"Philippe Noriel Q.","family":"Pascua","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton P.","family":"Chesnokov","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Champion","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"De La Cruz","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunho","family":"Jang","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Hatta","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Guo","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Uyeki","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Di","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevens","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T.","family":"Davis","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa V.","family":"Gubareva","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2023.109860"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07849-4"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02542-24"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08054-z"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2414610"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03905-2"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2906.230103"},{"key":"e_1_3_4_9_1","first-page":"44","article-title":"High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents\u2013United States, 2005-06 influenza season","volume":"55","author":"CDC","year":"2006","unstructured":"CDC. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents\u2013United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep. 2006;55:44\u201346. [cited 2025 Sep 10]. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5502a7.htm","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106217"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.112"},{"key":"e_1_3_4_12_1","unstructured":"CDC. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease; 2025a [cited 2025 Sept 10]. Available from: https:\/\/www.cdc.gov\/bird-flu\/hcp\/clinicians-evaluating-patients\/interim-guidance-treatment-humans.html"},{"key":"e_1_3_4_13_1","unstructured":"CDC. Interim guidance for follow-up of close contacts of persons infected with novel influenza A viruses associated with severe human disease or with potential to cause severe human disease and use of antiviral medications for post-exposure prophylaxis; 2025b [cited 2025 Sept 10]. Available from: https:\/\/www.cdc.gov\/bird-flu\/hcp\/clinicians-evaluating-patients\/interim-guidance-treatment-humans.html"},{"key":"e_1_3_4_14_1","unstructured":"Centers for Disease Control and Prevention. Interim guidance on influenza antiviral post-exposure prophylaxis of persons exposed to birds or other animals with novel influenza A viruses associated with severe human disease or with the potential to cause severe human disease; 2025c [cited 2025 Sep 10]. Available from: https:\/\/www.cdc.gov\/bird-flu\/hcp\/clinicians-evaluating-patients\/interim-guidance-post-exposure.html"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2415890"},{"key":"e_1_3_4_16_1","unstructured":"CDC. Influenza antiviral medications: summary for clinicians; 2023 [cited 2025 Sept 10]. Available from: https:\/\/www.cdc.gov\/flu\/hcp\/antivirals\/summary-clinicians.html"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2014.04.009"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.05.004"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105679"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad418"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2469643"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid3104.241820"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-3030-6"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw625"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2015.02.014"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/v2102269"},{"key":"e_1_3_4_27_1","unstructured":"World Health Organization. Laboratory methodologies for testing the antiviral susceptibility of influenza viruses: neuraminidase inhibitor (NAI); 2024 [cited 2025 July 22]. https:\/\/www.who.int\/teams\/global-influenza-programme\/laboratory-network\/quality-assurance\/antiviral-susceptibility-influenza\/neuraminidase-inhibitor"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105457"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa393"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky462"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27890-4"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2008.10.006"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1086\/504723"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00832-13"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.3.1800666"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022201"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02681-13"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004065"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02556-13"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm010528u"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716197"},{"key":"e_1_3_4_42_1","unstructured":"World Health Organization. Laboratory methodologies for testing the antiviral susceptibility of influenza viruses: Polymerase acidic (PA) inhibitor Baloxavir; 2024 [cited 2025 Jul 22]. https:\/\/www.who.int\/teams\/global-influenza-programme\/laboratory-network\/quality-assurance\/antiviral-susceptibility-influenza\/polymerase-acidic-protein-inhibitor"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad145"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01056-22"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15051154"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12760"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-018-0710-9"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008395"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-023-05958-5"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz472"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60791-5"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-01961-5"}],"container-title":["Emerging Microbes &amp; Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/22221751.2025.2601372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:39:53Z","timestamp":1766515193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/22221751.2025.2601372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/22221751.2025.2601372"],"URL":"https:\/\/doi.org\/10.1080\/22221751.2025.2601372","relation":{},"ISSN":["2222-1751"],"issn-type":[{"value":"2222-1751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2601372"}}